MacKay A R, Sang U H, Weinstein P R
J Neurosurg. 1978 Oct;49(4):597-601. doi: 10.3171/jns.1978.49.4.0597.
The association of myopathy with epsilon-aminocaproic acid (EACA) treatment after subarachnoid hemorrhage in two cases is reported. Clinical and laboratory findings and possible mechanisms are discussed in light of the known pharmacology of the drug. Recovery ensues if EACA treatment is terminated as soon as myopathy appears.
报告了两例蛛网膜下腔出血后使用ε-氨基己酸(EACA)治疗出现肌病的情况。根据该药物已知的药理学,讨论了临床和实验室检查结果及可能的机制。一旦出现肌病即停用EACA治疗,患者即可康复。